CVS Stock Recent News
CVS LATEST HEADLINES
Louisiana Attorney General Liz Murrill said on Tuesday that she had filed three separate lawsuits against CVS for unfair, deceptive, and unlawful practices that have harmed Louisiana patients, independent pharmacies, and the public at large.
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
U.S. health secretary Robert F. Kennedy Jr. met with major health insurers on Monday, extracting pledges that they will take additional measures to simplify their requirements for prior approval on medicines and medical services.
Leading health insurers announced on Monday that they have agreed to a set of measures aimed at connecting patients to care faster and reducing paperwork for providers.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Company commits to distinctive actions that will make it easier to navigate the health care system, access care, and achieve better health HARTFORD, Conn. , June 23, 2025 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), today announced its support of initiatives championed by American's Health Insurance Plans to improve the experience of doctors and patients.
Three Fortune 500 Industry Leaders—Energy Transfer, Verizon, and World Kinect—currently meet the 'dogcatcher' ideal of fair price and safer dividends. Analyst targets project 21% to 50% net gains for the top ten F500IL dividend dogs by June 2026, with average gains of 28.8%. Most top-yielding F500IL stocks remain overpriced, but a 60% market correction or dividend increases could make all ten fairly priced for income investors. Twelve F500IL stocks have negative free cash flow margins, making them unsafe for dividends; focus on the three 'safer' fair-priced options for now.
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS gains steam as rising margins, strong Medicare results, and cost cuts set it apart from UNH.
CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.